Update in ophthalmic and general pathology: Wegener's granulomatosis - A review of the ophthalmic manifestations

Canadian Journal of Ophthalmology

Volumn 32, Issue 3, 1997, Pages 149-152

  Heathcote, J Godfrey ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

anti neutrophil anticytoplasmic antibodies; granulomatous inflammation; orbit; scleritis; vasculitis; Wegener's granulomatosis

Indexed keywords

EYE INFLAMMATION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; ORBIT INFLAMMATION; REVIEW; WEGENER GRANULOMATOSIS;

EID: 0030914916     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
2. Huffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. D'Cruz DP, Baguley E, Asherson RA, Hughes GRV. Ear, nose and throat symptoms in subacute Wegener's granulomatosis. BMJ 1989;299:419-22.
4. Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990;14:556-64.
5. Goulart RA, Mark EJ, Rosen S. Tumefactions as an extravascular manifestation of Wegener's granulomatosis. Am J Surg Pathol 1995;19:145-53.
6. Brouwer E, Huitema MG, Mulder AHL, et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994;45:1120-31.
7. Kallenberg CGM, Mulder AHL, Tervaert JWC. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93:675-82.
8. Specks U, Homburger HA. Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc 1994;69:1197-8.
9. Rao JK, Alien NB, Feussner JR, Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995;346:926-31.
10. Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. Ann Intern Med 1995;123:925-32.
11. Markey BA, Warren JS. Use of antineutrophil cytoplasmic antibody assay to distinguish between vasculitic disease activity and complications of cytotoxic therapy. Am J Clin Pathol 1994;102:589-94.
12. Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med 1977;63:131-41.
13. Foster WP, Greene JS, Millman B. Wegener's granulomatosis presenting as ophthalmoplegia and optic neuropathy. Otolaryngol Head Neck Surg 1995;112:758-62.
14. Case records of the Massachusetts General Hospital 39-1994. N Engl J Med 1994;331:1143-9.
15. Kalina PH, Lie JT, Campbell RJ, Garrity JA. Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis. Ophthalmology 1992;99:120-4.
16. Janknecht P, Mittelviefhaus H, Loeffler KU. Sclero-choroidal granuloma in Wegener's granulomatosis simulating a uveal melanoma. Retina 1995;15:150-3.
17. Syed NA. Wegener's scleritis masquerading as an intraocular tumor. Eastern Ophthalmic Pathology Society meeting; 1996 September.
18. Kalina PH, Garrity JA, Herman DC, et al. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor. Mayo Clin Proc 1990;65:1110-7.
19. Jolly SS, Brownstein S, Jordan DR, Munro SM, Keystone EC. Scleritis in a patient with limited Wegener's granulomatosis and Takayasu's arteritis. Can J Ophthalmol 1995;30:371-3.
20. Soukiasian SH, Foster CS, Niles JL, Raizman MB. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology 1992;99:125-32.
21. Valesini G, Priori R, Conti F. Saddle nose [letter]. N Engl J Med 1995;333:525-26.
22. Power WJ, Rodriguez A, Neves R, et al. Disease relapse in patients with ocular manifestations of Wegener granulomatosis. Ophthalmology 1995;102:154-60.
23. Kaufman AH, Niles JL, Foster CS. ANCA test in ophthalmic inflammatory disease. Int Ophthalmol Clin 1994;34:215-27.
24. Jordan DR, Addison DJ. Wegener's granulomatosis. Eyelid and conjunctival manifestations as the presenting feature in two individuals. Ophthalmology 1994;101:602-7.
25. Tullo AB, Durrington P, Graham E, et al. Florid xanthelasmata (yellow lids) in orbital Wegener's granulomatosis. Br J Ophthalmol 1995;79:453-6.
26. Hardwig PW, Bartley GB, Garrity JA. Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis. Ophthalmology 1992;99: 133-9.
27. DeRemee RA. Empiricism and Wegener's granulomatosis. N Engl J Med 1996;335:54-5.
28. Stegeman CA, Tervaert JWC, Sluiter WJ, et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7.
29. Stegeman CA, Tervaert JWC, deJong PE, et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
30. Dictor M, Cervin A, Kalm O, Rambech E. Sinonasal T-cell lymphoma in the differential diagnosis of lethal midline granuloma using in situ hybridization for Epstein-Barr virus RNA. Mod Pathol 1996;9:7-14.